Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Marc Goodman is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/15/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/25/2025 | OPT | Buy Now | Opthea | $3.31 | -69.79% | Marc Goodman73% | $12 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/10/2025 | AXSM | Buy Now | Axsome Therapeutics | $102.56 | 46.26% | Marc Goodman73% | $110 → $150 | Maintains | Outperform | Get Alert |
| 12/04/2024 | RLMD | Buy Now | Relmada Therapeutics | $0.30 | 232.45% | Marc Goodman73% | $10 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 09/23/2024 | BHVN | Buy Now | Biohaven | $18.32 | 227.51% | Marc Goodman73% | $55 → $60 | Maintains | Outperform | Get Alert |
| 04/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $22.97 | 39.31% | Marc Goodman73% | → $32 | Initiates | → Outperform | Get Alert |
| 03/11/2024 | AMLX | Buy Now | Amylyx Pharma | $3.88 | — | Marc Goodman73% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/26/2023 | BLTE | Buy Now | Belite Bio | $56.47 | -55.73% | Marc Goodman73% | → $25 | Initiates | → Outperform | Get Alert |
| 03/01/2023 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman73% | → $0.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/30/2023 | DNLI | Buy Now | Denali Therapeutics | $13.19 | 279.08% | Marc Goodman73% | → $50 | Initiates | → Outperform | Get Alert |
| 01/24/2023 | BHVN | Buy Now | Biohaven | $18.32 | 31% | Marc Goodman73% | → $24 | Initiates | → Outperform | Get Alert |
| 01/23/2023 | RLMD | Buy Now | Relmada Therapeutics | $0.30 | 3224.47% | Marc Goodman73% | $42 → $10 | Maintains | Outperform | Get Alert |
| 01/23/2023 | MRNS | Buy Now | Marinus Pharma | — | — | Marc Goodman73% | $27 → $23 | Maintains | Outperform | Get Alert |
| 01/19/2023 | EOLS | Buy Now | Evolus | $10.03 | 99.4% | Marc Goodman73% | $18 → $20 | Maintains | Outperform | Get Alert |
| 11/29/2022 | AXSM | Buy Now | Axsome Therapeutics | $102.56 | -17.12% | Marc Goodman73% | $65 → $85 | Maintains | Outperform | Get Alert |
| 11/15/2022 | STSA | Buy Now | Satsuma Pharma | — | — | Marc Goodman73% | $15 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $97.03 | 18.52% | Marc Goodman73% | $100 → $115 | Maintains | Market Perform | Get Alert |
| 10/26/2022 | BIIB | Buy Now | Biogen | $116.97 | 165.03% | Marc Goodman73% | $270 → $310 | Maintains | Outperform | Get Alert |
| 10/10/2022 | STSA | Buy Now | Satsuma Pharma | — | — | Marc Goodman73% | $5 → $15 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/08/2022 | AMLX | Buy Now | Amylyx Pharma | $3.88 | 1188.66% | Marc Goodman73% | $31 → $50 | Maintains | Outperform | Get Alert |
| 08/22/2022 | AXSM | Buy Now | Axsome Therapeutics | $102.56 | -26.87% | Marc Goodman73% | $50 → $75 | Maintains | Outperform | Get Alert |
| 08/16/2022 | ELYM | Buy Now | Eliem Therapeutics | — | — | Marc Goodman73% | $9 → $4 | Maintains | Outperform | Get Alert |
| 08/11/2022 | AVDL | Buy Now | Avadel Pharmaceuticals | $7.78 | 54.24% | Marc Goodman73% | $6 → $12 | Maintains | Outperform | Get Alert |
| 08/11/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $33.90 | 35.69% | Marc Goodman73% | $40 → $46 | Maintains | Outperform | Get Alert |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Marc Goodman73% | $170 → $270 | Maintains | Outperform | Get Alert |
| 08/09/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.84 | 41.51% | Marc Goodman73% | $27 → $21 | Maintains | Outperform | Get Alert |
| 08/05/2022 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman73% | $4 → $3 | Maintains | Outperform | Get Alert |
| 08/04/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $101.74 | 106.4% | Marc Goodman73% | $200 → $210 | Maintains | Outperform | Get Alert |
| 07/14/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | Marc Goodman73% | → $170 | Initiates | → Outperform | Get Alert |
| 07/11/2022 | SAGE | Buy Now | Sage Therapeutics | $7.42 | 439.08% | Marc Goodman73% | $50 → $40 | Maintains | Market Perform | Get Alert |
| 07/11/2022 | ELYM | Buy Now | Eliem Therapeutics | — | — | Marc Goodman73% | $13 → $9 | Maintains | Outperform | Get Alert |
| 07/11/2022 | ACIU | Buy Now | AC Immune | $1.51 | 562.25% | Marc Goodman73% | $15 → $10 | Maintains | Outperform | Get Alert |
| 07/11/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.84 | 81.94% | Marc Goodman73% | $31 → $27 | Maintains | Outperform | Get Alert |
| 05/27/2022 | AVDL | Buy Now | Avadel Pharmaceuticals | $7.78 | -22.88% | Marc Goodman73% | $18 → $6 | Maintains | Outperform | Get Alert |
| 05/11/2022 | BHVN | Buy Now | Biohaven | $18.32 | — | Marc Goodman73% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/28/2022 | ALKS | Buy Now | Alkermes | $27.43 | -1.57% | Marc Goodman73% | $24 → $27 | Maintains | Market Perform | Get Alert |
| 04/26/2022 | OPT | Buy Now | Opthea | $3.31 | 655.29% | Marc Goodman73% | → $25 | Initiates | → Outperform | Get Alert |
| 04/26/2022 | ELYM | Buy Now | Eliem Therapeutics | — | — | Marc Goodman73% | $33 → $13 | Maintains | Outperform | Get Alert |
| 04/21/2022 | ITCI | Buy Now | Intra-Cellular Therapies | $131.92 | -46.94% | Marc Goodman73% | $65 → $70 | Maintains | Outperform | Get Alert |
| 04/21/2022 | BIIB | Buy Now | Biogen | $116.97 | 130.83% | Marc Goodman73% | $300 → $270 | Maintains | Outperform | Get Alert |
| 04/21/2022 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman73% | $10 → $4 | Maintains | Outperform | Get Alert |
| 04/21/2022 | ALKS | Buy Now | Alkermes | $27.43 | -8.86% | Marc Goodman73% | $24 → $25 | Maintains | Market Perform | Get Alert |
| 03/31/2022 | AMLX | Buy Now | Amylyx Pharma | $3.88 | 698.97% | Marc Goodman73% | $50 → $31 | Maintains | Outperform | Get Alert |
| 03/22/2022 | MRNS | Buy Now | Marinus Pharma | — | — | Marc Goodman73% | $30 → $27 | Maintains | Outperform | Get Alert |
| 03/03/2022 | GMTX | Buy Now | Gemini Therapeutics | — | — | Marc Goodman73% | $10 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/02/2022 | ITCI | Buy Now | Intra-Cellular Therapies | $131.92 | -50.73% | Marc Goodman73% | $50 → $65 | Maintains | Outperform | Get Alert |
| 03/02/2022 | AXSM | Buy Now | Axsome Therapeutics | $102.56 | -51.25% | Marc Goodman73% | $65 → $50 | Maintains | Outperform | Get Alert |
| 02/25/2022 | SAGE | Buy Now | Sage Therapeutics | $7.42 | 573.85% | Marc Goodman73% | $60 → $50 | Maintains | Market Perform | Get Alert |
| 02/01/2022 | AMLX | Buy Now | Amylyx Pharma | $3.88 | 1188.66% | Marc Goodman73% | → $50 | Initiates | → Outperform | Get Alert |
| 01/24/2022 | GMTX | Buy Now | Gemini Therapeutics | — | — | Marc Goodman73% | $15 → $10 | Maintains | Outperform | Get Alert |
| 01/24/2022 | BIIB | Buy Now | Biogen | $116.97 | 156.48% | Marc Goodman73% | $325 → $300 | Maintains | Outperform | Get Alert |
| 12/21/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $2.19 | 586.5% | Marc Goodman73% | $24 → $15 | Maintains | Outperform | Get Alert |
| 12/20/2021 | ZGNX | Buy Now | Zogenix | — | — | Marc Goodman73% | $37 → $32 | Maintains | Outperform | Get Alert |
| 12/20/2021 | SAGE | Buy Now | Sage Therapeutics | $7.42 | 708.63% | Marc Goodman73% | $70 → $60 | Maintains | Market Perform | Get Alert |
| 12/20/2021 | RLMD | Buy Now | Relmada Therapeutics | $0.30 | 13862.77% | Marc Goodman73% | $50 → $42 | Maintains | Outperform | Get Alert |
| 12/20/2021 | MRNS | Buy Now | Marinus Pharma | — | — | Marc Goodman73% | $32 → $30 | Maintains | Outperform | Get Alert |
| 12/20/2021 | JAZZ | Buy Now | Jazz Pharmaceuticals | $101.74 | 96.57% | Marc Goodman73% | $230 → $200 | Maintains | Outperform | Get Alert |
| 12/20/2021 | ITCI | Buy Now | Intra-Cellular Therapies | $131.92 | -62.1% | Marc Goodman73% | $45 → $50 | Maintains | Outperform | Get Alert |
| 12/20/2021 | GMTX | Buy Now | Gemini Therapeutics | — | — | Marc Goodman73% | $25 → $15 | Maintains | Outperform | Get Alert |
| 12/20/2021 | BIIB | Buy Now | Biogen | $116.97 | 177.85% | Marc Goodman73% | $450 → $325 | Maintains | Outperform | Get Alert |
| 12/20/2021 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman73% | $12 → $10 | Maintains | Outperform | Get Alert |
| 12/20/2021 | ACIU | Buy Now | AC Immune | $1.51 | 893.38% | Marc Goodman73% | $17 → $15 | Maintains | Outperform | Get Alert |
| 11/11/2021 | XENE | Buy Now | Xenon Pharmaceuticals | $33.90 | 17.99% | Marc Goodman73% | $34 → $40 | Maintains | Outperform | Get Alert |
| 11/09/2021 | AXSM | Buy Now | Axsome Therapeutics | $102.56 | -36.62% | Marc Goodman73% | $75 → $65 | Maintains | Outperform | Get Alert |
| 11/09/2021 | ALKS | Buy Now | Alkermes | $27.43 | -12.5% | Marc Goodman73% | $27 → $24 | Maintains | Market Perform | Get Alert |
| 09/07/2021 | ELYM | Buy Now | Eliem Therapeutics | — | — | Marc Goodman73% | → $33 | Initiates | → Outperform | Get Alert |
| 08/10/2021 | AXSM | Buy Now | Axsome Therapeutics | $102.56 | -26.87% | Marc Goodman73% | $115 → $75 | Maintains | Outperform | Get Alert |
| 08/06/2021 | ZGNX | Buy Now | Zogenix | — | — | Marc Goodman73% | $42 → $37 | Maintains | Outperform | Get Alert |
| 08/05/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.84 | 88.68% | Marc Goodman73% | $31 → $28 | Maintains | Outperform | Get Alert |
| 07/29/2021 | ALKS | Buy Now | Alkermes | $27.43 | -8.86% | Marc Goodman73% | $23 → $25 | Maintains | Market Perform | Get Alert |
| 06/18/2021 | JAZZ | Buy Now | Jazz Pharmaceuticals | $101.74 | 126.06% | Marc Goodman73% | $210 → $230 | Maintains | Outperform | Get Alert |
| 06/16/2021 | SAGE | Buy Now | Sage Therapeutics | $7.42 | 843.4% | Marc Goodman73% | $90 → $70 | Maintains | Market Perform | Get Alert |
| 06/10/2021 | BIIB | Buy Now | Biogen | $116.97 | 306.09% | Marc Goodman73% | $380 → $475 | Maintains | Outperform | Get Alert |
| 05/13/2021 | GRAY | Buy Now | Graybug Vision | — | — | Marc Goodman73% | $322 → $70 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/12/2021 | STSA | Buy Now | Satsuma Pharma | — | — | Marc Goodman73% | $4 → $5 | Maintains | Market Perform | Get Alert |
| 05/12/2021 | BHVN | Buy Now | Biohaven | $18.32 | 473.14% | Marc Goodman73% | $115 → $105 | Maintains | Outperform | Get Alert |
| 05/06/2021 | NBIX | Buy Now | Neurocrine Biosciences | $97.03 | 3.06% | Marc Goodman73% | $110 → $100 | Maintains | Market Perform | Get Alert |
| 04/08/2021 | GMTX | Buy Now | Gemini Therapeutics | — | — | Marc Goodman73% | → $25 | Initiates | → Outperform | Get Alert |
| 03/12/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $2.19 | 906.86% | Marc Goodman73% | → $22 | Initiates | → Outperform | Get Alert |
| 03/09/2021 | GRAY | Buy Now | Graybug Vision | — | — | Marc Goodman73% | $630 → $322 | Maintains | Outperform | Get Alert |
| 03/02/2021 | XENE | Buy Now | Xenon Pharmaceuticals | $33.90 | -17.4% | Marc Goodman73% | $25 → $28 | Maintains | Outperform | Get Alert |
| 02/04/2021 | BIIB | Buy Now | Biogen | $116.97 | 224.87% | Marc Goodman73% | $430 → $380 | Maintains | Outperform | Get Alert |
| 02/04/2021 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Marc Goodman73% | $200 → $220 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/11/2020 | ALKS | Buy Now | Alkermes | $27.43 | -16.15% | Marc Goodman73% | $18 → $23 | Maintains | Market Perform | Get Alert |
| 12/07/2020 | BHVN | Buy Now | Biohaven | $18.32 | 555.02% | Marc Goodman73% | $85 → $120 | Maintains | Outperform | Get Alert |
| 11/13/2020 | APTX | Buy Now | Aptinyx | — | — | Marc Goodman73% | $14 → $12 | Maintains | Outperform | Get Alert |
| 11/10/2020 | NBIX | Buy Now | Neurocrine Biosciences | $97.03 | 3.06% | Marc Goodman73% | $120 → $100 | Maintains | Market Perform | Get Alert |
| 11/09/2020 | BIIB | Buy Now | Biogen | $116.97 | 226.58% | Marc Goodman73% | $402 → $382 | Maintains | Outperform | Get Alert |
| 11/05/2020 | BIIB | Buy Now | Biogen | $116.97 | 243.68% | Marc Goodman73% | $342 → $402 | Maintains | Outperform | Get Alert |
| 10/20/2020 | GRAY | Buy Now | Graybug Vision | — | — | Marc Goodman73% | → $490 | Initiates | → Outperform | Get Alert |
| 10/02/2020 | XENE | Buy Now | Xenon Pharmaceuticals | $33.90 | -35.1% | Marc Goodman73% | → $22 | Initiates | → Outperform | Get Alert |
| 09/15/2020 | MRNS | Buy Now | Marinus Pharma | — | — | Marc Goodman73% | $24 → $32 | Maintains | Outperform | Get Alert |
| 09/11/2020 | STSA | Buy Now | Satsuma Pharma | — | — | Marc Goodman73% | $35 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/19/2020 | BIIB | Buy Now | Biogen | $116.97 | 192.38% | Marc Goodman73% | $350 → $342 | Maintains | Outperform | Get Alert |
| 08/06/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.84 | 250.4% | Marc Goodman73% | $56 → $52 | Maintains | Outperform | Get Alert |
| 08/04/2020 | NBIX | Buy Now | Neurocrine Biosciences | $97.03 | 23.67% | Marc Goodman73% | $105 → $120 | Maintains | Market Perform | Get Alert |
| 04/03/2020 | EOLS | Buy Now | Evolus | $10.03 | 49.55% | Marc Goodman73% | $25 → $15 | Maintains | Outperform | Get Alert |
| 03/13/2020 | ULTA | Buy Now | Ulta Beauty | $359.15 | -24.82% | Marc Goodman73% | $300 → $270 | Maintains | Buy | Get Alert |
| 02/06/2020 | BIIB | Buy Now | Biogen | $116.97 | 250.52% | Marc Goodman73% | $350 → $410 | Maintains | Outperform | Get Alert |
| 12/06/2019 | SAGE | Buy Now | Sage Therapeutics | $7.42 | — | Marc Goodman73% | — | Upgrade | Underperform → Market Perform | Get Alert |
| 11/26/2019 | EOLS | Buy Now | Evolus | $10.03 | 149.25% | Marc Goodman73% | → $25 | Initiates | → Outperform | Get Alert |
| 11/19/2019 | ABBV | Buy Now | AbbVie | $176.84 | -45.71% | Marc Goodman73% | $79 → $96 | Maintains | Buy | Get Alert |
| 11/19/2019 | AGN | Buy Now | Allergan | — | — | Marc Goodman73% | $189 → $203 | Downgrade | Buy → Neutral | Get Alert |
| 10/23/2019 | BIIB | Buy Now | Biogen | $116.97 | 199.22% | Marc Goodman73% | $256 → $350 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/13/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $14.84 | 236.93% | Marc Goodman73% | $21 → $50 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/12/2019 | AGN | Buy Now | Allergan | — | — | Marc Goodman73% | $172 → $189 | Maintains | Buy | Get Alert |
| 09/12/2019 | ABBV | Buy Now | AbbVie | $176.84 | -55.33% | Marc Goodman73% | $85 → $79 | Upgrade | Neutral → Buy | Get Alert |
| 08/30/2019 | ULTA | Buy Now | Ulta Beauty | $359.15 | -16.47% | Marc Goodman73% | $365 → $300 | Maintains | Buy | Get Alert |
| 05/09/2019 | AGN | Buy Now | Allergan | — | — | Marc Goodman73% | $173 → $172 | Maintains | Buy | Get Alert |
| 04/23/2019 | BHVN | Buy Now | Biohaven | $18.32 | 265.72% | Marc Goodman73% | $50 → $67 | Maintains | Outperform | Get Alert |
| 04/09/2019 | ZGNX | Buy Now | Zogenix | — | — | Marc Goodman73% | $60 → $48 | Maintains | Outperform | Get Alert |
| 04/08/2019 | AXSM | Buy Now | Axsome Therapeutics | $102.56 | -75.62% | Marc Goodman73% | → $25 | Initiates | → Outperform | Get Alert |
| 04/03/2019 | AGN | Buy Now | Allergan | — | — | Marc Goodman73% | $174 → $173 | Maintains | Buy | Get Alert |
| 01/23/2019 | ABBV | Buy Now | AbbVie | $176.84 | -48.54% | Marc Goodman73% | $97 → $91 | Assumes | Neutral → Neutral | Get Alert |
| 12/07/2018 | ULTA | Buy Now | Ulta Beauty | $359.15 | -6.73% | Marc Goodman73% | $315 → $335 | Maintains | Buy | Get Alert |
| 09/07/2018 | ULTA | Buy Now | Ulta Beauty | $359.15 | -12.29% | Marc Goodman73% | $285 → $315 | Maintains | Buy | Get Alert |
| 08/31/2018 | ULTA | Buy Now | Ulta Beauty | $359.15 | -20.65% | Marc Goodman73% | $290 → $285 | Maintains | Buy | Get Alert |
| 05/21/2018 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | — | Marc Goodman73% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/13/2017 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman73% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/10/2017 | DEPO | Buy Now | Depomed | — | — | Marc Goodman73% | $6 → $7 | Maintains | Neutral | Get Alert |
| 11/08/2017 | JAZZ | Buy Now | Jazz Pharmaceuticals | $101.74 | 65.12% | Marc Goodman73% | $172 → $168 | Maintains | Buy | Get Alert |
| 10/30/2017 | IPXL | Buy Now | Impax Laboratories | — | — | Marc Goodman73% | $12 → $16 | Maintains | Sell | Get Alert |
| 10/30/2017 | MRK | Buy Now | Merck & Co | $78.04 | -14.15% | Marc Goodman73% | $72 → $67 | Maintains | Buy | Get Alert |
| 10/17/2017 | AGN | Buy Now | Allergan | — | — | Marc Goodman73% | $275 → $255 | Maintains | Buy | Get Alert |
| 10/13/2017 | ABBV | Buy Now | AbbVie | $176.84 | -46.28% | Marc Goodman73% | $92 → $95 | Maintains | Neutral | Get Alert |
| 10/12/2017 | SCMP | Buy Now | Sucampo Pharmaceuticals | — | — | Marc Goodman73% | $19 → $15 | Maintains | Buy | Get Alert |
| 10/06/2017 | BMY | Buy Now | Bristol-Myers Squibb | $49.89 | 44.32% | Marc Goodman73% | $62 → $72 | Maintains | Buy | Get Alert |
| 10/05/2017 | PRGO | Buy Now | Perrigo | $25.00 | 292% | Marc Goodman73% | $84 → $98 | Maintains | Buy | Get Alert |
| 09/25/2017 | JAZZ | Buy Now | Jazz Pharmaceuticals | $101.74 | 69.05% | Marc Goodman73% | $175 → $172 | Maintains | Buy | Get Alert |
| 09/25/2017 | ABBV | Buy Now | AbbVie | $176.84 | — | Marc Goodman73% | — | Downgrade | Buy → Neutral | Get Alert |
| 07/31/2017 | MRK | Buy Now | Merck & Co | $78.04 | -7.74% | Marc Goodman73% | $70 → $72 | Maintains | Buy | Get Alert |
| 03/20/2017 | NEOS | Buy Now | Neos Therapeutics | — | — | Marc Goodman73% | — | Downgrade | Buy → Neutral | Get Alert |
| 10/03/2016 | DEPO | Buy Now | Depomed | — | — | Marc Goodman73% | $20 → $26 | Maintains | Neutral | Get Alert |
| 08/19/2016 | MRK | Buy Now | Merck & Co | $78.04 | -10.3% | Marc Goodman73% | $62 → $70 | Maintains | Buy | Get Alert |
| 08/03/2016 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman73% | $85 → $92 | Maintains | Buy | Get Alert |
| 07/07/2016 | DEPO | Buy Now | Depomed | — | — | Marc Goodman73% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/09/2016 | SCMP | Buy Now | Sucampo Pharmaceuticals | — | — | Marc Goodman73% | → $20 | Initiates | → Buy | Get Alert |
| 02/09/2016 | DEPO | Buy Now | DepoMed | — | — | Marc Goodman73% | → $22 | Initiates | → Buy | Get Alert |
| 11/16/2015 | PRGO | Buy Now | Perrigo | $25.00 | 700% | Marc Goodman73% | → $200 | Upgrade | Neutral → Buy | Get Alert |
| 04/27/2015 | PRGO | Buy Now | Perrigo | $25.00 | — | Marc Goodman73% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/17/2015 | IPXL | Buy Now | Impax Laboratories | — | — | Marc Goodman73% | — | Downgrade | Neutral → Sell | Get Alert |
| 02/04/2015 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman73% | $107 → $120 | Maintains | Buy | Get Alert |
| 07/22/2014 | AGN | Buy Now | Allergan | — | — | Marc Goodman73% | — | Upgrade | Neutral → Buy | Get Alert |
| 05/09/2014 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman73% | $84 → $91 | Maintains | Buy | Get Alert |
| 05/08/2014 | AGN | Buy Now | Allergan | — | — | Marc Goodman73% | $138 → $180 | Downgrade | Buy → Neutral | Get Alert |
| 04/09/2014 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman73% | $43 → $84 | Upgrade | Sell → Buy | Get Alert |
| 04/09/2014 | MNK | Buy Now | Mallinckrodt | — | — | Marc Goodman73% | $43 → $84 | Upgrade | Sell → Buy | Get Alert |
| 04/10/2013 | AGN | Buy Now | Allergan | — | — | Marc Goodman73% | $112 → $128 | Maintains | Buy | Get Alert |
| 03/07/2013 | IPXL | Buy Now | Impax Laboratories, Inc. | — | — | Marc Goodman73% | $23 → $17 | Maintains | Neutral | Get Alert |
| 02/25/2013 | PRGO | Buy Now | Perrigo Company | $25.00 | 420% | Marc Goodman73% | $115 → $130 | Upgrade | Neutral → Buy | Get Alert |
| 02/25/2013 | PRGO | Buy Now | Perrigo Company | $25.00 | — | Marc Goodman73% | — | Upgrade | Neutral → Buy | Get Alert |
| 07/20/2012 | PRGO | Buy Now | Perrigo | $25.00 | 380% | Marc Goodman73% | → $120 | Downgrade | Buy → Neutral | Get Alert |
| 04/10/2012 | IPXL | Buy Now | Impax Laboratories | — | — | Marc Goodman73% | $24 → $26 | Maintains | Neutral | Get Alert |
| 03/29/2012 | AGN | Buy Now | Allergan | — | — | Marc Goodman73% | $100 → $107 | Maintains | Buy | Get Alert |
| 03/05/2012 | PRGO | Buy Now | Perrigo | $25.00 | 380% | Marc Goodman73% | $115 → $120 | Maintains | Buy | Get Alert |
| 02/29/2012 | IPXL | Buy Now | Impax Laboratories | — | — | Marc Goodman73% | $21 → $24 | Maintains | Neutral | Get Alert |
